Viruses 2013, 5(5), 1292-1324; doi:10.3390/v5051292
Review

Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease

1 Inserm, U1110, Institute of Virology, Strasbourg 67000, France 2 Université de Strasbourg, Strasbourg 67000, France 3 Universitaires de Strasbourg, Strasbourg 67000, France
* Author to whom correspondence should be addressed.
Received: 18 March 2013; in revised form: 10 April 2013 / Accepted: 27 April 2013 / Published: 23 May 2013
(This article belongs to the Section Animal Viruses)
PDF Full-text Download PDF Full-Text [1013 KB, uploaded 23 May 2013 09:12 CEST]
Abstract: Hepatitis C virus (HCV) is a leading cause of chronic liver disease, including chronic hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Hepatitis C infection associates with lipid and lipoprotein metabolism disorders such as hepatic steatosis, hypobetalipoproteinemia, and hypocholesterolemia. Furthermore, virus production is dependent on hepatic very-low-density lipoprotein (VLDL) assembly, and circulating virions are physically associated with lipoproteins in complexes termed lipoviral particles. Evidence has indicated several functional roles for the formation of these complexes, including co-opting of lipoprotein receptors for attachment and entry, concealing epitopes to facilitate immune escape, and hijacking host factors for HCV maturation and secretion. Here, we review the evidence surrounding pathogenesis of the hepatitis C infection regarding lipoprotein engagement, cholesterol and triglyceride regulation, and the molecular mechanisms underlying these effects.
Keywords: Hepatitis C virus; lipoproteins; apolipoproteins; apoE; apoB; cholesterol; triglyceride; viral attachment; entry; assembly; secretion; viral immune escape; lipid disorder

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Felmlee, D.J.; Hafirassou, M.L.; Lefevre, M.; Baumert, T.F.; Schuster, C. Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease. Viruses 2013, 5, 1292-1324.

AMA Style

Felmlee DJ, Hafirassou ML, Lefevre M, Baumert TF, Schuster C. Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease. Viruses. 2013; 5(5):1292-1324.

Chicago/Turabian Style

Felmlee, Daniel J.; Hafirassou, Mohamed L.; Lefevre, Mathieu; Baumert, Thomas F.; Schuster, Catherine. 2013. "Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease." Viruses 5, no. 5: 1292-1324.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert